Forbes JM - Search Results

1

Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.

Tesch G, Sourris KC, Summers SA, McCarthy D, Ward MS, Borg DJ, Gallo LA, Fotheringham AK, Pettit AR, Yap FY, Harcourt BE, Tan AL, Kausman JY, Nikolic-Paterson D, Kitching AR, Forbes JM. Tesch G, et al. Among authors: forbes jm. Diabetologia. 2014 Sep;57(9):1977-85. doi: 10.1007/s00125-014-3291-z. Epub 2014 Jun 24. Diabetologia. 2014. PMID: 24957662

2

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.

Cooper ME, Thallas V, Forbes J, Scalbert E, Sastra S, Darby I, Soulis T. Cooper ME, et al. Diabetologia. 2000 May;43(5):660-4. doi: 10.1007/s001250051355. Diabetologia. 2000. PMID: 10855541

3

Renoprotective effects of a novel inhibitor of advanced glycation.

Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME. Forbes JM, et al. Diabetologia. 2001 Jan;44(1):108-14. doi: 10.1007/s001250051587. Diabetologia. 2001. PMID: 11206401

4

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE).

Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME. Oldfield MD, et al. Among authors: forbes jm. J Clin Invest. 2001 Dec;108(12):1853-63. doi: 10.1172/JCI11951. J Clin Invest. 2001. PMID: 11748269 Free PMC article.

5

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME. Forbes JM, et al. FASEB J. 2003 Sep;17(12):1762-4. doi: 10.1096/fj.02-1102fje. Epub 2003 Jul 18. FASEB J. 2003. PMID: 12958202

6

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.

Davis BJ, Forbes JM, Thomas MC, Jerums G, Burns WC, Kawachi H, Allen TJ, Cooper ME. Davis BJ, et al. Among authors: forbes jm. Diabetologia. 2004 Jan;47(1):89-97. doi: 10.1007/s00125-003-1256-8. Epub 2003 Nov 29. Diabetologia. 2004. PMID: 14647892 Free article.

7

Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats.

Wigg SJ, Tare M, Forbes J, Cooper ME, Thomas MC, Coleman HA, Parkington HC, O'Brien RC. Wigg SJ, et al. Diabetologia. 2004 Jun;47(6):1038-46. doi: 10.1007/s00125-004-1411-x. Epub 2004 Jun 8. Diabetologia. 2004. PMID: 15184978

8

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.

Forbes JM, Thomas MC, Thorpe SR, Alderson NL, Cooper ME. Forbes JM, et al. Kidney Int Suppl. 2004 Nov;(92):S105-7. doi: 10.1111/j.1523-1755.2004.09225.x. Kidney Int Suppl. 2004. PMID: 15485399 Free article. Review.

9

A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-products.

Zimanyi MA, Denton KM, Forbes JM, Thallas-Bonke V, Thomas MC, Poon F, Black MJ. Zimanyi MA, et al. Among authors: forbes jm. Diabetologia. 2006 Apr;49(4):801-10. doi: 10.1007/s00125-006-0175-x. Epub 2006 Feb 23. Diabetologia. 2006. PMID: 16496120 Free article.

10

AGE, RAGE, and ROS in diabetic nephropathy.

Tan AL, Forbes JM, Cooper ME. Tan AL, et al. Among authors: forbes jm. Semin Nephrol. 2007 Mar;27(2):130-43. doi: 10.1016/j.semnephrol.2007.01.006. Semin Nephrol. 2007. PMID: 17418682 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters